OpenCongress is in beta. We'd love your feedback!Share feedback

OpenCongress 🇺🇸

S. 1040 · 119TH CONGRESSSenate · Apr 10, 2025

Drug Competition Enhancement Act

Introduced

Senate

House

Resolving Differences

President

Became Law

Description

Drug Competition Enhancement Act

Committee on the Judiciary. Ordered to be reported with an amendment favorably.

Apr 3, 2025

HearingSenateMeeting

Apr 3, 2025 · 14:15

Business meeting to consider S.527, to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, S.1040, to amend the Federal Trade Commission Act to prohibit product hopping, S.1041, to amend title 35, United States Code, to address the infringement of patents that claim biological products, S.1097, to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, S.1095, to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and S.1096, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products, and the nomination of Patrick David Davis, of Maryland, to be an Assistant Attorney General, Department of Justice.

Committee

Senate Committee on the Judiciary

View full hearing

Video

Committee on the Judiciary. Reported by Senator Grassley with an amendment. Without written report.

Apr 10, 2025

Committee on the Judiciary. Reported by Senator Grassley with an amendment. Without written report.

Apr 10, 2025

Placed on Senate Legislative Calendar under General Orders. Calendar No. 43.

Apr 10, 2025

Passed House

Resolving Differences

To President

Became Law